J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s fastest growing, professionally managed, global pharmaceutical company manufacturing a wide range of innovative specialty medicines for domestic and international markets. A flagship company of the Unique Group, it is also known to many as “Unique”.

Its product portfolio consists of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs). Some of the products within these categories enjoy leadership positions in the Indian as well as the foreign markets.

The Company is strategically focused on Research & Development (R & D) and is totally committed to respond promptly to the market needs by developing quality products at affordable prices for the masses. With a strong base of 11 state-of-the-art manufacturing units (including three US FDA approved Tablet & API plants) and two DSTC approved R&D centers, the company has entered a dynamic phase of expansion into newer and faster growing therapeutic segments such as anti-diabetics, CNS and Respiratory.

J B Chemical & Pharmaceuticals Ltd. is a customer driven and financially sound company which consistently enhances value for its shareholders by rewarding them with healthy dividends year after year. With its Head Office situated in Mumbai (India), it has a large global presence with operations in over 50 countries across the world.

52% of the Company’s revenue comes from exports to USA, Europe, Latin America, Africa and South East Asia. To further enhance its strength in foreign markets, JBCPL has also entered into joint ventures and strategic tie ups with key partners in USA and many more countries.